These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18364723)

  • 1. Clinically isolated syndrome: the rationale for early treatment.
    Comi G
    Nat Clin Pract Neurol; 2008 May; 4(5):234-5. PubMed ID: 18364723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-interferon and multiple sclerosis].
    Clanet M
    Rev Neurol (Paris); 1993; 149(8-9):443-4. PubMed ID: 8009140
    [No Abstract]   [Full Text] [Related]  

  • 3. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
    Comi G
    Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of multiple sclerosis to prevent neurologic damage.
    Coyle PK
    Neurology; 2008 Dec; 71(24 Suppl 3):S3-7. PubMed ID: 19064872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Interferon and multiple sclerosis: not a final solution to the problem.
    Compston A
    Br J Hosp Med; 1995 Jun 7-20; 53(11):547-9, 551, 553. PubMed ID: 7655750
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
    Koch MW; Mostert JP; de Vries JJ; De Keyser J
    Neurology; 2007 Apr; 68(14):1163; author reply 1163-4. PubMed ID: 17404207
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis. Treatment is shifting.
    Mayo Clin Health Lett; 2003 Jan; 21(1):6. PubMed ID: 12619619
    [No Abstract]   [Full Text] [Related]  

  • 8. Early onset multiple sclerosis: more emphasis on early treatment.
    Minagar A
    Neuropediatrics; 2006 Aug; 37(4):207-8. PubMed ID: 17177146
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of multiple sclerosis with beta-interferon.
    Poser CM
    Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability, adherence, and patient outcomes.
    Ross AP
    Neurology; 2008 Dec; 71(24 Suppl 3):S21-3. PubMed ID: 19064871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis 2].
    Bol P
    Ned Tijdschr Tandheelkd; 1999 Jul; 106(7):276-7. PubMed ID: 11930375
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis and other related inflammatory disorders of the central nervous system: differential diagnosis and treatment.
    Lyon-Caen O; Fontaine B; Gout O; Tourbah A
    Acta Neurol Belg; 1994; 94(2):92-7. PubMed ID: 8036882
    [No Abstract]   [Full Text] [Related]  

  • 13. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
    Di Pauli F; Reindl M; Ehling R; Schautzer F; Gneiss C; Lutterotti A; O'Reilly E; Munger K; Deisenhammer F; Ascherio A; Berger T
    Mult Scler; 2008 Sep; 14(8):1026-30. PubMed ID: 18632775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensifying the care of MS-patients].
    Fredrikson S; Hillert J; Link H; Söderström M; Isberg B
    Lakartidningen; 1996 Mar; 93(11):1015-20. PubMed ID: 8656807
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 16. Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?
    Giacomini PS; Arnold DL; Bar-Or A; Antel JP
    Arch Neurol; 2009 Jan; 66(1):19-20. PubMed ID: 19139295
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon beta in multiple sclerosis.
    Arnason BG
    Neurology; 1993 Apr; 43(4):641-3. PubMed ID: 8469315
    [No Abstract]   [Full Text] [Related]  

  • 18. Misdiagnosis of multiple sclerosis and beta-interferon.
    Poser CM
    Lancet; 1997 Jun; 349(9069):1916. PubMed ID: 9217787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of disseminated sclerosis with beta-inferferon--why and why not?].
    Sørensen PS; De Neergaard L
    Ugeskr Laeger; 1999 May; 161(19):2790. PubMed ID: 10412314
    [No Abstract]   [Full Text] [Related]  

  • 20. New treatment measurements for treatment effects on relapses and progression.
    Tintoré M; Sastre-Garriga J
    J Neurol Sci; 2008 Nov; 274(1-2):80-3. PubMed ID: 18822433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.